Skip to content

Dr. Caroline Hofmans

Active Private limited companyfounded 2023active for 3 yearsSinte Apoloniastraat 50, 9300 AalstKBO/BCE: BE 1002.423.635

Lifetime

2 annual accounts with figures on one time axis
peak of €129,801 in 2025
€129,801▲ 45.2%
peak of €95,489 in 2025
€95,489▲ 37.6%
peak of €169,901 in 2025
€169,901▲ 128%
€33,152▲ 66.0%
Board1 name since 2023
1 director
Documentsfilings and deeds
02-07-202629 days before the deadline
2025micro format
Gross margin from €89,385 to €129,801Result from €69,413 to €95,489Equity from €74,413 to €169,901Debts from €19,970 to €33,152Cash from €54,773 to €167,962

Key points

from the 2025 annual accounts

Equity

€169,901 ▲ 128%
€74,4002024€170,0002025

Equity rose in 2025 from €74,413 to €169,901.

Turnover

≈ €240,000 estimated

The micro format states no turnover.

Liquidity

5.28 was 2.99 in 2024

Short-term debts rose from €19,590 to €32,265.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,330 companies had the same profile as Dr. Caroline Hofmans has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,330 companies, not a prediction for Dr. Caroline Hofmans. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 20-11-2023
  • 100 sharesdeed of 22-11-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1002423635
Incorporation Founding capital of €5,000, 100 shares · Founded by · appointed as director · published on 22-11-2023 · Gazette deed
First establishment Sinte Apoloniastraat 50, Aalst
All 6 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Caroline Hofmans Aalst €203,054 €129,801 83.7% -
Dr. Jonas Denduyver Merelbeke-Melle €208,083 €116,773 69.5% -
Dr. Ann-Sophie De Vos - dermatologie Wortegem-Petegem €217,125 €137,165 75.9% -
MB Ortho Sint-Martens-Latem €202,299 €127,705 82.5% -
DR. JUSTINE WYTSMAN Kortrijk €208,681 €129,402 85.2% -
Dr. EVH, oogarts Leuven €210,575 €130,742 78.1% -
Docteur Nathalie Michaux Assesse €196,552 €131,044 77.3% -

These companies have the same main activity as Dr. Caroline Hofmans: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €197,000 and €217,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 20-11-2023Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.352.731.7339300 Aalst, since 20-11-2023
Financial year end
31 December
Peppol
Reachable since 01-01-2026
Company details

Annual accounts 2025

€203,054▲ 115%
Filing
Filed on 02-07-2026, 29 days before the end of the filing period
Financials

Insights on Dr. Caroline Hofmans

Dr. Caroline Hofmans has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €169,901 and a net result of €95,489.

Its solvency ranks better than 75% of 21,385 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Caroline Hofmans

What is the company number of Dr. Caroline Hofmans?
The company number of Dr. Caroline Hofmans is 1002.423.635. The VAT number is the same number with BE in front: BE 1002.423.635.
Where is Dr. Caroline Hofmans based?
The registered office is at Sinte Apoloniastraat 50, 9300 Aalst.Company details
What does Dr. Caroline Hofmans do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Caroline Hofmans?
Dr. Caroline Hofmans is a private limited company (BV).
When was Dr. Caroline Hofmans founded?
Dr. Caroline Hofmans was founded on 20-11-2023.
Is Dr. Caroline Hofmans still active?
Yes, Dr. Caroline Hofmans is an active enterprise in the KBO register.
What is the turnover of Dr. Caroline Hofmans?
The turnover in financial year 2025 is about €240,000. This figure is estimated from the gross margin of €129,801 and 40 comparable companies (NACE 86220). It probably lies between €200,000 and €320,000.Financials
Is Dr. Caroline Hofmans profitable?
In financial year 2025, Dr. Caroline Hofmans made a profit of €95,489.
Where can I find the annual accounts of Dr. Caroline Hofmans?
Dr. Caroline Hofmans filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Caroline Hofmans due?
Dr. Caroline Hofmans must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.